women undergoing gynaecological surgery (Diamond, 1995).
inconsistent results. In an attempt to reduce the inflammatory Postsurgical adhesion formation is a significant clinical reaction at the site of the peritoneal trauma, corticosteroids problem within every surgical specialism. Due to the probwere used and later, the anti-adhesive properties of calciumlems that adhesions cause, a wide variety of adjunctive channel blockers and antihistamines were studied. More recent treatments to prevent the formation and reformation of studies deal with non-steroidal anti-inflammatory drugs adhesions have been proposed. One of the modalities that (NSAIDs), tissue plasminogen activator (t-PA) and selective has been studied extensively and that has been showing immunosuppressors [i.e. tumour necrosis factor α (TNF-α) the most promising results is the so-called barrier method.
and interleukin-1 (IL-1) antibodies]. Various results with all The purpose of the present study was to compare the of these treatments have been reported (diZerega, 1994 ; Pijlman efficacy of five of these barrier materials in the prevention Bakkum et al., 1996; Risberg, 1997) .
of postsurgical adhesion formation in a standardized rat
One of the modalities that has been studied extensively and adhesion model. It was concluded that no beneficial effect of that has been showing the most promising results is the soRinger's lactate on adhesion formation was seen. Significant called barrier method. With the barrier technique, surgically reductions (P < 0.0001) in adhesion percentages compared traumatized surfaces are kept covered during mesothelial to control animals were seen with Polyactive™, regeneration, thus preventing adherence of adjacent structures PRECLUDE Peritoneal Membrane™, Seprafilm™ and and reducing adhesion formation. Barriers consist of intraTissucol™, but only PRECLUDE Peritoneal Membrane abdominal fluids such as Hyskon™ (32% Dextran 70) and and Seprafilm significantly reduced adhesions (P < 0.01)
Ringer's lactate, as well as of solid materials such as carboxywhen the barrier-treated peritoneal defects were compared methylcellulose, Interceed™ (oxidized regenerated cellulose), with contralateral control-side peritoneal defects. The Poloxamer 407™, Polyactive™ (composed of a polyethylresults of our study suggest that Seprafilm and PRECLUDE eneglycol and polybuthyleneterephthalate co-polymer), Peritoneal Membrane are superior to Tissucol and Polyac-PRECLUDE Peritoneal Membrane™ (expanded polytetrative in preventing adhesion formation. When Polyactive fluoroethylene), fibrin glue (Tissucol™) and Seprafilm™ was still attached to the site of application during the second (bioresorbable membrane based on a chemically modified form laparotomy, similar results to Seprafilm and PRECLUDE of hyaluronic acid and carboxymethylcellulose). All these Peritoneal Membrane were seen. Future studies on the materials have a unique composition and characteristics with efficacy of a material to decrease adhesion formation should limitations and advantages for use in the clinical setting. The always include a comparison of several control materials ideal barrier should have the following characteristics: antiin the same model. Our study indicates that Seprafilm adhesive, high biocompatibility, resorbable, adherent to the or PRECLUDE Peritoneal Membrane might be used as traumatized surface, effective on oozing surface, applicable standards of control.
through the laparoscope, and not too expensive. As yet, such Key words: adhesions/comparative study/prevention/rat model an ideal barrier does not exist. While for instance Hyskon is outdated as an anti-adhesion adjuvant because of the possible serious side effects such as anaphylactic shock (Trimbos Kemper and Veering, 1989) , generalized coagulation problems Introduction or labial oedema, degradable Interceed and Poloxamer 407 can only be applied on dry, non-bleeding surfaces, while Postsurgical adhesion formation is a significant clinical problem within every surgical specialism. Specifically after almost PRECLUDE Peritoneal Membrane is non-degradable and ideally requires a second operation for removal. every intra-abdominal surgical procedure, these adhesions are a frequently ensuing complication. Bowel obstruction and/or
The purpose of the present study was to compare the efficacy of Polyactive, PRECLUDE Peritoneal Membrane, Ringer's chronic pelvic pain are common complications due to this
The adhesion model that we used in this study is a highly lactate, Seprafilm and Tissucol in the prevention of postsurgical reproducible and semi-quantitative rat model for the evaluation of adhesion formation in a standardized rat adhesion model therapeutic modalities used for the prevention of postoperative adheand compare our results with recent literature concerning sion formation, and was developed specifically for this purpose these barriers. (Bakkum et al., 1994) . The model consisted of bilateral excision of a parietal peritoneal defect of 1.5ϫ1.2 cm, which was closed with three Vicryl (polyglactin 910; Ethicon, Amersfoort, The Netherlands)
Materials and methods
5-0 sutures in 2ϭ2 surgical knots (Holmlund, 1974) . After suturing Description of barrier materials the peritoneal defect, the uterine horn was approximated to the defect by loosely suturing the uterine horn to the peritoneum both proximally The Polyactive barrier (1000 Polyactive™ 60/40; Isotis, Bilthoven, and distally of the defect with two interrupted Prolene (polypropylene; The Netherlands) is composed of a polyethyleneglycol and polybuthyEthicon) 6-0 sutures. These Prolene sutures were placed outside of leneterephthalate co-polymer in a porous/dense bilayered mesh with the margins of the peritoneal defect so as not to interfere with a thickness of 230 µm; the barrier is resorbable and can be applied adhesion formation at the area to be scored. The uterine horn was without suturing (Bakkum et al., 1995) . The dense layer functions as then clamped with an artery forceps three times opposite to the three a barrier and allows mesothelial overgrowth, while the porous layer Vicryl sutures during 10 s per localization. No attempt at haemostasis (pore size 106-150 µm) is intended to allow ingrowth of vascularized, was made during the procedure. Blood loss was quantified subjectively fibrous tissue attaching the barrier permanently.
by grading the amount of blood after the excision of the defect as PRECLUDE Peritoneal Membrane (W.L.Gore & Associates, b.v., either mild, moderate or severe. Blood clots were removed in every 's Hertogenbosch, The Netherlands) is a unique configuration of animal with a moist cotton swab after the procedure had been expanded polytetrafluoroethylene (ePTFE) that was initially used as completed. During surgery, the bowel tissues were kept moist with a substitute for the pericardium (The Surgical Membrane Study wet gauze in order to avoid dehydration; there was no intraperitoneal Group, 1992) . The barrier has a thickness of 0.1 mm, and tissue attachment is inhibited by the barrier's extremely small pore size irrigation. The musculoperitoneal layer was closed evertedly with a (Ͻ1 µm) and non-absorbable nature. It is antithrombogenic, nonrunning Vicryl 5-0 suture, and the cutaneous layer with Vicryl 3-reactive, easy to handle at laparotomy, maintains flexibility and limits 0 sutures. adhesion formation between adjacent tissues.
Ringer's lactate solution (Fresenius Kabi, 's Hertogenbosch, The Experimental design Netherlands) is an isotonic crystalloid solution that is widely used
The 110 rats, and thus 220 peritoneal defects, were assigned randomly after reproductive surgery (Tulandi, 1993) . Although the mechanism to six different groups; five treatment groups (Polyactive, PRECLUDE of action of Ringer's lactate instillation is not clear, it is supposed Peritoneal Membrane, Ringer's lactate, Seprafilm and Tissucol) each that the presence of a high volume of the solution in the abdominal consisting of 20 rats, and a control group of 10 rats. The rats were cavity separates raw peritoneal surfaces and thus prevents adhesion randomized after the surgical procedure had been completed. The 10 formation.
sham-operated control rats were subjected to a similar surgical Seprafilm (Genzyme b.v., Naarden, The Netherlands) is a bioresorbprocedure, but without the application of a barrier material. All the able membrane based on a chemically modified form of hyaluronic barrier materials, except for Ringer's lactate, were assigned randomly acid and carboxymethylcellulose that is designed to reduce postoperato one peritoneal defect for unilateral application in each rat, so that tive adhesion formation (Alponat et al., 1997) . Within 24 h of each rat could also serve as its own control. Polyactive, PRECLUDE application, Seprafilm turns to gel while remaining in place to separate Peritoneal Membrane and Seprafilm were cut to size, measuring adhesiogenic tissues during the first few days when adhesions are 18ϫ20 mm, before application onto the peritoneal defect. likely to develop, and it is cleared from the body within 28 days.
Polyactive and Seprafilm were applied without suturing, whereas Tissucol (Immuno, b.v., Raamsdonkveer, The Netherlands) is a PRECLUDE Peritoneal Membrane was applied to the peritoneal biological two-component glue; one component consists of defect with four Gore-Tex™ ('s Hertogenbosch, The Netherlands) mg coagulation proteins per ml (of which 70-110 mg is fibrinogen), CV-6 sutures. A 6 ml aliquot of the Ringer's lactate solution was and the second component contains 500 IU/ml thrombin in a 40 deposited intraperitoneally before closure of the abdomen. Tissucol mmol/l calcium chloride solution. Tissucol is used clinically to (0.1 ml) was applied to the defect by means of the Duploject-system; achieve haemostasis, to seal or glue tissue and to support wound at 2 min after application, the peritoneal site was rinsed with 1 ml healing. Indications include, for instance, the control of local and 0.9% NaCl solution, after which the fluid was removed with a pipette diffuse bleeding, the sealing of suture line bleeding, the sealing and before abdominal closure. coating of vascular prostheses, and the control of haemorrhage in hepatic and splenic trauma. More recent studies suggest that Tissucol Scoring of the adhesions may also decrease intra-abdominal adhesion formation (de Virgilio et al., 1990) .
At 2 weeks after surgery, the rats were killed and adhesions scored and documented macroscopically according to their extent. All Surgical techniques adhesions were scored by the same researcher. The extent of adhesion formation was quantified by dividing the peritoneal defect through A total of 110 female inbred Wistar rats (Harlan CPB, Zeist, The the three Vicryl sutures into eight areas, each of 12.5%. An adhesion Netherlands) of reproductive age, weighing 180-200 g, was used.
score of 100% could thus be achieved maximally (see Figure 1) . The The rats were anaesthetized with a combination of halothane and extent of adhesions was documented by drawing them onto a diagram nitrous oxide inhalation, after which the abdomen was shaved and similar to Figure 1 . After the adhesions were scored and documented swabbed with iodine in preparation for surgery. The surgical procedin all the rats, a second retrospective scoring was carried out on all ures were performed under aseptic, but not sterile, conditions. Surgical the drawings in order to check for any variability in terms of scoring gloves were washed extensively with saline before the start of the the adhesions. During this second scoring, the researcher was blinded operative procedure in order to remove any particles of powder. All surgical procedures were performed by the same researcher.
to the type of treatment in the rats. Attention was also paid to the (P ϭ 0.009) and Seprafilm (P ϭ 0.001).
NS ϭ not significant.
As shown in Table II second laparotomy was lower than that of the average score of all the Polyactive barriers (40% and 57% respectively), no Results significant difference was found when compared with other There were no surgical or postoperative mortalities, and in all barrier-treated peritoneal defects. The films that were detached animals that were studied the adhesion formation was confined could generally be retrieved in either the omentum, pelvic fat to the peritoneal defects. No significant differences were body or mesosalpinx of the uterine horn. Significant reductions found between the initial scoring of the adhesions and the were also seen with Polyactive that was still attached (n ϭ 9) retrospective scoring using the drawings made of the adhesions to the site of application during the second laparotomy. at postoperative evaluation in each rat. Adhesion percentages No significant differences were found with respect to the referred to below are those from the initial scoring. At type of adhesions formed (filmy, organized or cohesive) for postoperative evaluation, the control animals that were operated the barrier-treated peritoneal defects when compared with the on without appliance of a barrier showed an average adhesion control-side peritoneal defects, and between the barrier-treated percentage of 79 Ϯ 24% per peritoneal defect (Table I) .
peritoneal defects of the five groups of barrier-treated animals. There were no significant differences between mean adhesion Also, no influence of mild, moderate or severe blood loss on percentages of the control-side peritoneal defects of the barrierthe extent and/or type of adhesions could be established (data treated animals and those of the control animals (Table I) . No not shown). significant difference was observed between the control-side peritoneal defects of the barrier-treated animals and the peritonDiscussion eal defects of the control animals with respect to uterine horn involvement.
In the present study, five different barrier materials were studied for their efficacy in the prevention of postoperative The peritoneal defects of the control animals and Ringer's adhesion formation in a rat adhesion model. The results of the four groups of barrier-treated animals, the PRECLUDE Peritoneal Membrane-treated animals had the lowest adhesion demonstrate that installation of Ringer's lactate solution has no effect on preventing adhesion formation. Earlier results in percentage (41%), and when comparing barrier-treated peritoneal defects with contralateral control-side peritoneal defects, animal models of the use of Ringer's lactate in the prevention of postoperative adhesion formation are inconsistent. It has significant reductions were seen only with PRECLUDE Peritoneal Membrane (P ϭ 0.009) and Seprafilm (P ϭ 0.001). been suggested previously (Yaacobi and Goldberg, 1991 ) that extensive irrigation with Ringer's lactate in surgery must be Also, a significant decrease in uterine horn involvement was found only in this group; only two of the 20 animals had viewed with caution. In the mouse model they used, even unabraded peritoneum formed adhesions with Ringer's lactate involvement of the uterine horn (P ϭ 0.0005). The latter finding was probably due to the non-degradable character of irrigation, while no irrigation clearly yielded superior results. Similarly, in a study in rats , no beneficial this barrier material, preventing the uterine horn from coming into contact with the peritoneal defect and most of the pelvic effect was found following the instillation of Ringer's lactate solution. However, others (Pagidas and Tulandi, 1992) found fat body. Most of the adhesions that did form were found in areas of wrinkles or at margins of the barrier due to the small a significant reduction in the formation of adhesions in a study in rats with the use of intraperitoneal Ringer's lactate, and its size of the barrier (18ϫ20 mm) in relation to the size of the peritoneal defect (15ϫ12 mm). efficacy was superior to that of Interceed, Gore-Tex and amniotic membrane. They concluded that, apart from the antiIn several clinical studies, PRECLUDE Peritoneal Membrane has also been shown to be efficacious in the prevention adhesive properties, other advantages of Ringer's lactate are that it is inexpensive, readily available, and has minimal side of postoperative adhesion formation. One multicentre clinical study examined the efficacy of PRECLUDE Peritoneal Memeffects. Other animal studies also reported a benefit from Ringer's lactate in preventing adhesions (Caballero and brane in the reduction of peritoneal adhesion formation and reformation after treatment for moderate to severe pelvic Tulandi, 1993) . However, clinical data on the use of Ringer's lactate show no beneficial effect. In two adhesive disease, significant deperitonealization or myomectomy (The Surgical Membrane Study Group, 1992) . At secondclinical studies, the effect of Dextran solution on postoperative adhesion formation was compared with that of Ringer's lactate look laparoscopy, in all patient groups a significant reduction in adhesion formation and reformation was found compared solution (Rosenburg and Board, 1984; Jansen, 1985) . In both studies, no beneficial effect of the Ringer's lacate was found, with uncovered control sites. In a second study, the efficacy of PRECLUDE Peritoneal Membrane was compared with and many of the patients treated with Ringer's lacate had more adhesions at the time of second-look laparoscopy than before Interceed in a multicentre, non-blinded, randomized trial in patients having bilateral pelvic sidewall adhesions undergoing the initial procedure.
The results obtained with Polyactive were somewhat disapreconstructive surgery and second-look laparoscopy in which each barrier was allocated randomly to the left or right sidewall pointing. Although there were no significant differences between Polyactive, Seprafilm, PRECLUDE Peritoneal Memof every patient (Haney et al., 1995) . PRECLUDE Peritoneal Membrane was associated with fewer adhesions to the pelvic brane and Tissucol when compared with control and Ringer's lactate-treated animals, 11 of the 20 barriers detached from sidewall than Interceed. The effect of PRECLUDE Peritoneal Membrane was also evaluated in reducing postmyomectomy the site of application. In a previous study (Bakkum et al., 1995) , Polyactive was found to be efficacious in the prevention adhesion formation (The Myomectomy Adhesion Multicenter Study Group, 1995) . In 27 patients having myomectomy with of postoperative adhesion formation in the same rat uterine horn model, and although also in that study 50% of the barriers at least two incisions on the uterine fundus and posterior uterine wall of similar length, the two incision sites were had detached from the site of application (in contrast to our results), a much lower mean adhesion percentage was found randomly assigned to be covered with PRECLUDE Peritoneal Membrane, or were left uncovered. At second-look laparosfor the barriers that were in place at second laparotomy. Initial clinical results with the Polyactive barrier in patients copy, 15 of 27 incisions covered with PRECLUDE Peritoneal Membrane (55.6%) and only two of 27 uncovered sites (7.4%) undergoing myomectomy are promising, although further investigation is needed to achieve better initial adherence at were completely free of adhesions, and the mean adhesion score at the PRECLUDE Peritoneal Membrane™ was significantly the original application site of this new, degradable barrier.
After the initial use of PRECLUDE Peritoneal Membrane lower than at the control sites. Although efficacious in these clinical studies, important drawbacks of this barrier were that as a passive biological membrane substitute (pericardium and peritoneum), it was also found to be an effective barrier for it must be sutured in place, which makes it difficult and timeconsuming to apply-especially laparoscopically-and that it adhesion prevention in most of the animal studies conducted in mice, rats, rabbits and monkeys (Goldberg et al., 1987;  must be removed in a second procedure, because of its nondegradable character. Boyers et al., 1988; Montz et al., 1992; Pagidas and Tulandi, 1992; Haney and Doty, 1993; Grow et al., 1994; Harris et al., The Seprafilm barrier has significantly reduced the incidence, extent and severity of postoperative adhesions in a variety of 1995) . Also, in the present study PRECLUDE Peritoneal Membrane was found to be effective in the prevention of animal models (Alponat et al., 1997; Burns et al., 1997) , and also in two large, prospective, randomized controlled, postoperative adhesions when compared with control and Ringer's lactate-treated animals. Although no significant differmulticentre clinical studies. One of these studies involved gynaecological surgery using myomectomy in which patients ence was found between the barrier-treated peritoneal defects randomly received Seprafilm wrapped over the entire uterus, It can be concluded that the adhesion model we used in the present study was very consistent in producing adhesions. or no treatment (Diamond, 1995) . The other study involved general surgery where patients undergoing colectomy and Furthermore, no beneficial effect of Ringer's lactate on adhesion formation was seen. Significant reductions in adhesion ileal pouch-anal anastomosis with diverting loop ileostomy randomly did, or did not, receive Seprafilm placed under the percentages compared with control animals were seen with Polyactive, PRECLUDE Peritoneal Membrane, Seprafilm and midline incision prior to closure of the abdomen (Becker et al., 1996) . In both trials, Seprafilm significantly reduced Tissucol, but only PRECLUDE Peritoneal Membrane and Seprafilm significantly reduced adhesions when the barrierpostoperative adhesion development. In the present study, Seprafilm significantly reduced adhesion formation to 43% treated peritoneal defects were compared with contralateral control-side peritoneal defects. Thus, the results of our study compared with 79% in both control and Ringer's lactatetreated animals, and also when comparing barrier-treated suggest that Seprafilm and PRECLUDE Peritoneal Membrane are superior to Tissucol and Polyactive in preventing adhesion peritoneal defects with contralateral control-side peritoneal defects (P ϭ 0.001).
formation. Future studies on the efficacy of a material to decrease adhesion formation should always include a comparThe role of Tissucol in the formation of adhesions only became the subject of study more recently. According to the ison of several control materials in the same model. Our study indicates that Seprafilm or PRECLUDE Peritoneal Membrane traditional model of adhesion formation-that fibrin serves as a matrix for ingrowth of fibroblasts with their subsequent might be used as standards of control. elaboration of collagen-Tissucol seemed to have the potential for markedly increasing adhesion formation. However, several studies in rats and rabbits where peritoneal defects were treated
